HIV-associated lipodystrophy: Description, pathogenesis, and molecular pathways
- 1 April 2002
- journal article
- review article
- Published by Springer Nature in Current Diabetes Reports
- Vol. 2 (2) , 116-124
- https://doi.org/10.1007/s11892-002-0070-x
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Lipodystrophy in 685 HIV-1–Treated Patients: Influence of Antiretroviral Treatment and Immunovirological ResponseHIV Research & Clinical Practice, 2001
- Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and LipodystrophyClinical Infectious Diseases, 2001
- Association of Severe Insulin Resistance With Both Loss of Limb Fat and Elevated Serum Tumor Necrosis Factor Receptor Levels in HIV LipodystrophyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Suppression of Preadipocyte Differentiation and Promotion of Adipocyte Death by HIV Protease InhibitorsJournal of Biological Chemistry, 2000
- Lipodystrophy, Metabolic Disorders, and Human Immunodeficiency Virus Infection: Aquitaine Cohort, France, 1999Clinical Infectious Diseases, 2000
- The Mechanism of Insulin Resistance Caused by HIV Protease Inhibitor TherapyJournal of Biological Chemistry, 2000
- HIV Protease Inhibitor-Related Lipodystrophy SyndromeClinical Infectious Diseases, 2000
- Surgical implantation of adipose tissue reverses diabetes in lipoatrophic miceJournal of Clinical Investigation, 2000
- Adverse effects of reverse transcriptase inhibitorsAIDS, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998